Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

TransTech Adding $30M To Extended Series E Financing

July 12, 2004

By Aaron Lorenzo

Myriad Receives $14.2M Federal Contract To Research Pathogens

July 9, 2004

By Aaron Lorenzo

Myriad Receives $14.2M Federal Contract To Research Pathogens

July 9, 2004

By Aaron Lorenzo

Celera Partners Antigens With Abbott In Oncology Agreement

July 8, 2004

By Aaron Lorenzo

Celera Partners Antigens With Abbott In Oncology Agreement

July 8, 2004

By Aaron Lorenzo

FDA Clears NeutroSpec, Gives Palatin First Product Approval

July 7, 2004

By Aaron Lorenzo

FDA Clears NeutroSpec, Gives Palatin First Product Approval

July 7, 2004

By Aaron Lorenzo

Cerus Focusing On Vaccines; Intercept System Moved Aside

July 2, 2004

By Aaron Lorenzo

Cerus Focusing On Vaccines; Intercept System Moved Aside

July 2, 2004

By Aaron Lorenzo

Inhibitex Starts Veronate Hospital Infection Phase III Trial In Infants

July 1, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...